Repligen Corp (RGEN)
144.06
-1.87
(-1.28%)
USD |
NASDAQ |
Nov 07, 16:00
144.06
0.00 (0.00%)
After-Hours: 20:00
Repligen Revenue (TTM): 602.35M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 602.35M |
| March 31, 2024 | 607.45M |
| December 31, 2023 | 638.76M |
| September 30, 2023 | 669.78M |
| June 30, 2023 | 729.33M |
| March 31, 2023 | 777.80M |
| December 31, 2022 | 801.54M |
| September 30, 2022 | 801.30M |
| June 30, 2022 | 778.77M |
| March 31, 2022 | 734.10M |
| December 31, 2021 | 670.53M |
| September 30, 2021 | 592.66M |
| June 30, 2021 | 508.50M |
| March 31, 2021 | 433.01M |
| December 31, 2020 | 366.26M |
| September 30, 2020 | 327.09M |
| June 30, 2020 | 302.47M |
| March 31, 2020 | 285.70M |
| December 31, 2019 | 270.24M |
| September 30, 2019 | 252.71M |
| June 30, 2019 | 232.80M |
| March 31, 2019 | 209.84M |
| December 31, 2018 | 194.03M |
| September 30, 2018 | 183.70M |
| June 30, 2018 | 170.75M |
| Date | Value |
|---|---|
| March 31, 2018 | 155.48M |
| December 31, 2017 | 141.24M |
| September 30, 2017 | 125.22M |
| June 30, 2017 | 113.32M |
| March 31, 2017 | 110.04M |
| December 31, 2016 | 104.54M |
| September 30, 2016 | 100.39M |
| June 30, 2016 | 95.53M |
| March 31, 2016 | 87.81M |
| December 31, 2015 | 83.54M |
| September 30, 2015 | 78.48M |
| June 30, 2015 | 73.94M |
| March 31, 2015 | 68.04M |
| December 31, 2014 | 63.55M |
| September 30, 2014 | 62.54M |
| June 30, 2014 | 66.08M |
| March 31, 2014 | 68.04M |
| December 31, 2013 | 68.17M |
| September 30, 2013 | 71.60M |
| June 30, 2013 | 67.88M |
| March 31, 2013 | 65.90M |
| December 31, 2012 | 62.27M |
| September 30, 2012 | 52.08M |
| June 30, 2012 | 44.63M |
| March 31, 2012 | 35.02M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
270.24M
Minimum
Dec 2019
801.54M
Maximum
Dec 2022
573.56M
Average
607.45M
Median
Mar 2024
Revenue (TTM) Benchmarks
| West Pharmaceutical Services Inc | 2.876B |
| QuidelOrtho Corp | 2.835B |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 110.94M |
| Catheter Precision Inc | 0.436M |